Who We Are
At innoVitro, our team of scientists and engineers leads the industry as a Contract Research Organization (CRO) specializing in human-based cell analytics.
We excel in assessing functional and structural cellular readouts – including cell contractility, viability, connectivity and electrophysiology – with unmatched precision and throughput. Our cutting-edge technologies focus on speedlabel-free operationsreal-time analysis.
Our services are tailored to the needs of drug discovery, encompassing comprehensive preclinical safety assessments, toxicity evaluations, and efficacy studies of pharmaceutical and nutritional industries.
Reach out to test the effects of small moleculesbiopharmaceuticalsvector-based therapeuticsimmune therapeuticssiRNAs/miRNAsantibodies!
Cell-Based Assay Services
Explore our cell-based assay services, designed to monitor dynamic functional and cellular changes over time to gain valuable insights into contractile, morphological or general cellular responses.
Technologies
Discover our state-of-the-art cell-based assay technologies, the cornerstone of our services designed to elevate your cellular research fast and effectively!
Latest News
Ensuring Safety and Quality of Botanical Extracts in Food and Dietary Supplements
Safety and quality of botanical extracts in food and dietary supplements? This critical question was at the heart of the discussions at the Botanical Safety Consortium Summit, where our CEO, Matthias Gossmann, was co-presenting the important work of the Cardiotox Working Group alongside experts Shane R. Zhao, André Monteiro da Rocha and Joseph C. Wu. Together, we are driving forward collaborative efforts to address the safety concerns surrounding botanical ingredients and extracts.
LabINAR BREAK 4online eventEnhancing cardiac cell therapy and tissue engineering by magnetic clustering?
In this Labinar, we discuss magnetic targeting of transplanted cells and show a novel strategy of magnetically forced cell aggregation. Additionally, we will showcase the use of diseased hiPSC-CMs in the development of a personalized cardiac risk assessment strategy, spanning from 2D cultures to 3D organoid models.
Meet us at the 4th Next-Gen Organ-On-Chip & Organoids Workshop taking place in Basel, Switzerland, 13th - 14th of February 2025.
Join us at this exciting event and don’t miss the presentation by Bettina Lickiss, titled "A Microphysiological System For Chronic Cardiotoxicity Assessment: Insights from HESI Working Groups".
Our Trusted Partners & Clients
- O
- O
- O
- O
- O